Charles N. Blitzer
Keine laufenden Positionen mehr
Profil
Charles N.
Blitzer was the founder who founded PreEmptive Meds, Inc. in 2006 and served as President & Chief Executive Officer until 2008.
He was also President & Chief Executive Officer at Fulcrum Pharmaceuticals, Inc. from 2004 to 2005, at Barbeau Pharma, Inc. from 2005 to 2006, and Chairman at MGI PHARMA, Inc. in 2003.
He served as Director at Znomics, Inc. in 2008.
Mr. Blitzer holds an MBA from Rockhurst University, a graduate degree from American University, and an undergraduate degree from the University of Toledo (Ohio).
Ehemalige bekannte Positionen von Charles N. Blitzer
| Unternehmen | Position | Ende |
|---|---|---|
Znomics, Inc.
 Znomics, Inc. Financial ConglomeratesFinance Znomics, Inc. is a shell company, which is seeking and investigating potential assets, property or businesses to acquire and intend to commence operations in the future through the acquisition of a going concern. It was previously an exploration stage company that was set up to engage in the exploration of mineral properties. Znomics was founded on March 20, 2006 and is headquartered in Minneapolis, MN. | Direktor/Vorstandsmitglied | 03.12.2008 |
PreEmptive Meds, Inc.
 PreEmptive Meds, Inc. BiotechnologyHealth Technology PreEmptive Meds, Inc. develops and sales therapeutic nutraceuticals. Its all-natural, plant based formulations have been clinically proven to be safe and effective by hundreds of primary care physicians who have used its products in thousands of patients. The company was founded by Charles N. Blitzer and Joe Fenn in 2006 and is headquartered in Lebanon, NJ. | Vorstandsvorsitzender | 01.06.2008 |
| Barbeau Pharma, Inc. | Präsident | 01.04.2006 |
| Fulcrum Pharmaceuticals, Inc. | Präsident | 01.07.2005 |
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Vorstandsvorsitzender | 13.05.2003 |
Ausbildung von Charles N. Blitzer
| Rockhurst University | Masters Business Admin |
| American University | Graduate Degree |
| University of Toledo (Ohio) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
| Fulcrum Pharmaceuticals, Inc. | Health Technology |
| Barbeau Pharma, Inc. | |
PreEmptive Meds, Inc.
PreEmptive Meds, Inc. BiotechnologyHealth Technology PreEmptive Meds, Inc. develops and sales therapeutic nutraceuticals. Its all-natural, plant based formulations have been clinically proven to be safe and effective by hundreds of primary care physicians who have used its products in thousands of patients. The company was founded by Charles N. Blitzer and Joe Fenn in 2006 and is headquartered in Lebanon, NJ. | Health Technology |
Znomics, Inc.
Znomics, Inc. Financial ConglomeratesFinance Znomics, Inc. is a shell company, which is seeking and investigating potential assets, property or businesses to acquire and intend to commence operations in the future through the acquisition of a going concern. It was previously an exploration stage company that was set up to engage in the exploration of mineral properties. Znomics was founded on March 20, 2006 and is headquartered in Minneapolis, MN. | Finance |
